Senior Advisor 2 Services for the NINDS Helping to End Addiction Long-term Initiative, or NIH HEAL Initiative for the Pain Therapeutics Development Program (PTDP) External Oversight Committee (EOC) Subject Matter Expert (SME) Services

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

OMAS STRATEGIC BUYING CENTER - PROFESSIONAL SERVICES

Contract Value

Not provided

Codes & Classification
Solicitation Number

7571PS27Q00011

NAICS

541690 - Other Scientific and Technical Consulting Services

Classification Code

R499

Additional Details
Set Aside

None

Place of Performance

Bethesda, Maryland, UNITED STATES

SourceSAM
The Office of the Assistant Secretary for Financial Resources (ASFR), under the Department of Health and Human Services (HHS), is soliciting quotes for Senior Advisor 2 Services to support the National Institute of Neurological Disorders and Stroke (NINDS) Helping to End Addiction Long-term (HEAL) Initiative, specifically within the Pain Therapeutics Development Program (PTDP). This procurement seeks a highly qualified executive-level subject matter expert (SME) in pharmaceutical development and pain therapeutics to serve as a member of the HEAL External Oversight Committee (EOC), providing strategic guidance and technical feedback to NIH program leadership on drug discovery and development projects. **Purpose and Scope** The primary objective of this acquisition is to secure expert consulting services from a Senior Advisor 2 with extensive experience in drug discovery, development, pharmacology, and pain management. The selected contractor will contribute to the NIH HEAL Initiative, a cross-agency effort aimed at accelerating scientific solutions to address the national opioid crisis. The SME will advise on projects within the NINDS HEAL portfolio and, as needed, other NIH drug discovery and development programs, ensuring that the agency’s efforts are informed by the latest industry and scientific best practices. **Key Requirements and Deliverables** - The contractor must provide executive-level expertise in pharmaceutical development and pain therapeutics. - The SME will participate as a member of the HEAL External Oversight Committee, offering strategic and technical guidance. - Deliverables include feedback and recommendations to NIH leadership on drug discovery and development projects. - The anticipated level of effort is approximately 50 labor hours per year, with an option for up to an additional 50 hours annually. - The government may reimburse up to $2,000 per consultant per year for travel expenses, subject to prior approval. - All proposed key personnel must be employed by the contractor by the start of the contract period. - Responses must include resumes, letters of commitment, and a narrative demonstrating how personnel meet the evaluation criteria. - Contractors must provide evidence of relevant past performance, including details of similar projects, contract information, and personnel involved. **Contracting Entity and Location** - Contracting Entity: OMAS Strategic Buying Center - Professional Services, a federal office under HHS. - Department: Health and Human Services, Department of - Agency: Office of the Assistant Secretary for Financial Resources (ASFR) - Place of Performance: Bethesda, Maryland, United States **Classification Codes** - NAICS Code: 541690 (Other Scientific and Technical Consulting Services), 2022 version, small business size standard $19 million. - Product Service Code: R499 **Procurement Type and Set-Aside** - This is a competitive combined synopsis/solicitation for commercial services, issued as a Request for Quote (RFQ) under solicitation number 7571PS27Q00011. - The acquisition is set aside for small business concerns. - The government reserves the right to make one, multiple, or no awards. - The anticipated contract is a fixed-price purchase order with a base period from November 5, 2026, to November 4, 2027, and two option years extending through November 4, 2029. - The total contract duration, including options, will not exceed three years. **Special Considerations** - Compliance with FAR and HHSAR provisions and clauses is required, including those related to key personnel, information security, and accessibility. - Salary rate limitations apply: no NIH funds may be used to pay direct annual salary above Executive Schedule, Level II. - Contractors must be actively registered in the System for Award Management (SAM) at www.sam.gov at the time of quote submission. - Technical evaluation will consider personnel qualifications, price, and past performance. - Quotes must be submitted electronically by 12:00 PM Eastern Time on November 3, 2026, referencing solicitation number 7571PSQ00011. - Questions must be submitted by October 30, 2026, at 12:00 PM EST. **Contact Information** - Primary Contact: Dave Romley, Contract Specialist ([email protected]) - Secondary Contact: Michelle Cecilia ([email protected], 301-272-9118) **Constant Elements Throughout Contract Lifecycle** - The requirement for executive-level pharmaceutical and pain therapeutics expertise. - Participation in the HEAL External Oversight Committee. - Adherence to federal contracting standards and salary limitations. - Place of performance in Bethesda, Maryland. - Small business set-aside and NAICS classification. - Compliance with key personnel and security requirements. Contractors with proven experience in pharmaceutical development, pain therapeutics, and federal consulting are encouraged to review the Statement of Work (Attachment #1) and submit a comprehensive response demonstrating their qualifications, pricing, and relevant past performance. This opportunity is well-suited for small businesses specializing in scientific and technical consulting services, particularly those with expertise in drug discovery and pain management.
Documents6